Transplantation, HomologousHematopoietic Stem Cell TransplantationGraft vs Host DiseaseStem Cell TransplantationTransplantation ConditioningStem CellsHematologic NeoplasmsGraft vs Leukemia EffectGraft vs Tumor EffectTransplantation, AutologousLeukemiaTreatment OutcomeBone Marrow TransplantationTransplantation ChimeraRecurrenceHematopoietic Stem CellsRetrospective StudiesBusulfanVidarabinePeripheral Blood Stem Cell TransplantationTissue DonorsMyeloablative AgonistsRemission InductionEmbryonic Stem CellsAcute DiseaseHistocompatibility TestingAdult Stem CellsSurvival RateTime FactorsCytomegalovirus InfectionsLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft SurvivalLymphocyte DepletionT-LymphocytesMinor Histocompatibility AntigensPluripotent Stem CellsImmunosuppressive AgentsWhole-Body IrradiationSiblingsLymphocyte TransfusionPrecursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic SyndromesVirus ActivationHistocompatibilityFollow-Up StudiesAntilymphocyte SerumStem Cell NicheSalvage TherapyChimerismNeoplasm, ResidualSurvival AnalysisCell DifferentiationCytomegalovirusMultiple MyelomaHematopoietic Stem Cell MobilizationCombined Modality TherapyInduced Pluripotent Stem CellsNeural Stem CellsAnemia, AplasticRisk FactorsHepatic Veno-Occlusive DiseaseRoseolovirus InfectionsProspective StudiesMesenchymal Stromal CellsMultipotent Stem CellsPrimary MyelofibrosisCord Blood Stem Cell TransplantationMesenchymal Stem Cell TransplantationTransplantation ImmunologyDisease-Free SurvivalCells, CulturedTrans Fatty AcidsMice, Inbred C57BLIsoantigensBone Marrow CellsLeukemia, Myeloid, Accelerated PhaseCyclophosphamideFlow CytometryImmunosuppressionLeukocyte TransfusionHematologic DiseasesHLA AntigensLymphocyte Culture Test, MixedStem Cell FactorAntigens, CD34Antibodies, NeoplasmLeukemia, MyeloidFusion Proteins, bcr-ablImmunotherapy, AdoptiveBenzamidesGanciclovirImmunocompromised HostAntineoplastic Combined Chemotherapy ProtocolsPyrimidinesTransplantation, IsogeneicCell ProliferationReceptors, Purinergic P2X5AspergillosisAntineoplastic Agents